CareJourney Analysis Shows Breast Cancer Screenings Dropped During COVID-19, but Women Cared for by Physicians in Value-Based Care Arrangements Were Significantly More Likely to Be Screened
Retrieved on:
Tuesday, May 17, 2022
Research, Technology, Security, Public Policy, Government, Healthcare Reform, Networks, General Health, Health, Data Management, Science, Cancer, Physician, FFS, Prevent Cancer Foundation, Data analysis, Medicaid, Risk, COO, Survival, Breast cancer, Medicare Part D, Patient, Woman, Goal, Vaccine, Book, Health, Solution, African Americans, American Cancer Society, COVID-19, Medicare, Medicare Advantage, Acos, Life, VBC Zandhoven, VBC, Human, LinkedIn, Joe Biden, Twitter, Odds ratio, ACO, CEO, Pharmaceutical industry, Health insurance, Medical imaging, Facebook
However, patients cared for by physicians participating in value-based care (VBC) arrangements were far more likely to be screened for breast cancer than those who were not enrolled in a VBC program.
Key Points:
- However, patients cared for by physicians participating in value-based care (VBC) arrangements were far more likely to be screened for breast cancer than those who were not enrolled in a VBC program.
- In 2018-2019, an average of 4,513,772 women received a mammogram, between 2020-2021; the annual average was reduced to 4,014,750.
- Recent improvements in cancer patient outcomes have come in part from timely preventive cancer screenings, such as mammograms.
- The CareJourney breast cancer screening analysis was performed by using 100 percent of Medicare FFS population data (Part A, B, and D).